Promomed Group to take part in the International Export Forum “Made in Russia”

Promomed Group, one of the leaders of the Russian pharmaceutical market, will take part in the International Export Forum “Made in Russia”, which will be held in Moscow on October 19–20. The forum is a key international platform for discussing topical issues of export activities and developing practical solutions for the development of competitiveness of Russian companies in the international market and will be held for the fifth time this year. Representatives of Promomed Group will take part in the business program of the forum, discuss with participants and potential partners ways for cooperation and new developments in priority areas, including oncology, antiviral therapy, neurology, endocrinology and others.

The forum will bring together heads of federal and regional executive bodies, representatives of small, medium and large businesses, expert communities and business associations. The forum program will include both exhibition part and business part, round tables and plenary sessions. Particular attention at the forum this year will be paid to the regions of Russia. It is planned that the export potential of each territory will to covered as widely as possible. The exhibition will be divided into clusters: “Industry”, “Ecology”, “Smart City”, “IT”, “Medicine”, “Construction”, “Equipment for Agro-Industrial Complex”, “Education”, and “Consumer Goods”.

Within the business program at the Forum, participants will discuss the specifics of high-tech exports, its new geography, export prospects in the field of creative ideas and products, as well as other topics. The forum will also host the awarding of the laureates of the All-Russian competition "Exporter of the Year", which will mark companies that have managed to increase export volumes and successfully enter new markets.

The forum will award the laureates of the All-Russian contest “Exporter of the Year” to honor companies that have managed to increase export volumes and successfully enter new markets.

The development of the export direction is one of the priority directions for Promomed Group. Having its own strong production site (the Biokhimik plant in Saransk) and a strong R&D division with a portfolio including more than 190 new drugs, the Group is ready to consider a variety of options for cooperation with friendly states interested in high-quality Russian-made medicines or technologies. Promomed Group's strategic plans include a large–scale entry into foreign markets. In particular, along with the Middle East and the countries of Southeast Asia, other areas are also being considered including the countries of Africa.

Participation in the forum “Made in Russia” is a good opportunity for the Group to hold negotiations and discuss upcoming plans with potential partners, establish contacts with new companies and organizations.